Investment Analysts’ Recent Ratings Changes for Trupanion (TRUP)

Several analysts have recently updated their ratings and price targets for Trupanion (NASDAQ: TRUP):

• 2/17/2026 – Trupanion was upgraded by analysts at Weiss Ratings from a “sell (d+)” rating to a “hold (c-)” rating.
• 2/13/2026 – Trupanion had its price target lowered by analysts at Stifel Nicolaus from $38.00 to $35.00. They now have a “hold” rating on the stock.
• 2/13/2026 – Trupanion had its price target lowered by analysts at Piper Sandler from $60.00 to $45.00. They now have an “overweight” rating on the stock.
• 2/13/2026 – Trupanion was downgraded by analysts at Zacks Research from a “strong-buy” rating to a “hold” rating.
• 1/29/2026 – Trupanion had its price target lowered by analysts at Stifel Nicolaus from $42.00 to $38.00. They now have a “hold” rating on the stock.
• 1/14/2026 – Trupanion had its price target lowered by analysts at Cantor Fitzgerald from $50.00 to $42.00. They now have a “neutral” rating on the stock.
• 1/6/2026 – Trupanion was upgraded by analysts at Zacks Research from a “hold” rating to a “strong-buy” rating.
• 12/29/2025 – Trupanion had its “sell (d+)” rating reaffirmed by analysts at Weiss Ratings.
• 12/22/2025 – Trupanion had its “sell (d+)” rating reaffirmed by analysts at Weiss Ratings.

Insider Buying and Selling

In other Trupanion news, CFO Fawwad Qureshi sold 6,202 shares of the stock in a transaction dated Wednesday, November 26th. The shares were sold at an average price of $35.45, for a total transaction of $219,860.90. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, COO John R. Gallagher sold 6,383 shares of the business’s stock in a transaction that occurred on Friday, November 28th. The shares were sold at an average price of $34.82, for a total transaction of $222,256.06. Following the completion of the sale, the chief operating officer directly owned 32,721 shares in the company, valued at $1,139,345.22. This trade represents a 16.32% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last ninety days, insiders sold 32,853 shares of company stock valued at $1,181,863. 5.42% of the stock is currently owned by insiders.

Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company’s core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.

Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.